Stay updated with breaking news from Bio Techne. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Barclays PLC cut its position in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 30.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 137,243 shares of the biotechnology company’s stock after selling 60,285 shares during the quarter. Barclays PLC owned 0.09% of […]
Bio-Techne (NASDAQ:TECH – Get Free Report) is scheduled to be releasing its earnings data before the market opens on Tuesday, August 8th. Analysts expect Bio-Techne to post earnings of $0.49 per share for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this link. Bio-Techne Price Performance […]
Bio-Techne (NASDAQ:TECH) has had a rough week with its share price down 1.9%. However, stock prices are usually driven...
Amalgamated Bank reduced its stake in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 5.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 57,553 shares of the biotechnology company’s stock after selling 3,185 shares during the quarter. Amalgamated Bank’s holdings in Bio-Techne […]
/PRNewswire/ -- The liquid biopsy market size is estimated to grow by USD 1.74 billion from 2021 to 2026, according to Technavio. The market is estimated to...